Matches in SemOpenAlex for { <https://semopenalex.org/work/W2756993541> ?p ?o ?g. }
- W2756993541 endingPage "798" @default.
- W2756993541 startingPage "765" @default.
- W2756993541 abstract "Allergic rhinoconjunctivitis (AR) is an allergic disorder of the nose and eyes affecting about a fifth of the general population. Symptoms of AR can be controlled with allergen avoidance measures and pharmacotherapy. However, many patients continue to have ongoing symptoms and an impaired quality of life; pharmacotherapy may also induce some side-effects. Allergen immunotherapy (AIT) represents the only currently available treatment that targets the underlying pathophysiology, and it may have a disease-modifying effect. Either the subcutaneous (SCIT) or sublingual (SLIT) routes may be used. This Guideline has been prepared by the European Academy of Allergy and Clinical Immunology's (EAACI) Taskforce on AIT for AR and is part of the EAACI presidential project “EAACI Guidelines on Allergen Immunotherapy.” It aims to provide evidence-based clinical recommendations and has been informed by a formal systematic review and meta-analysis. Its generation has followed the Appraisal of Guidelines for Research and Evaluation (AGREE II) approach. The process included involvement of the full range of stakeholders. In general, broad evidence for the clinical efficacy of AIT for AR exists but a product-specific evaluation of evidence is recommended. In general, SCIT and SLIT are recommended for both seasonal and perennial AR for its short-term benefit. The strongest evidence for long-term benefit is documented for grass AIT (especially for the grass tablets) where long-term benefit is seen. To achieve long-term efficacy, it is recommended that a minimum of 3 years of therapy is used. Many gaps in the evidence base exist, particularly around long-term benefit and use in children." @default.
- W2756993541 created "2017-10-06" @default.
- W2756993541 creator A5004123017 @default.
- W2756993541 creator A5005445326 @default.
- W2756993541 creator A5006129133 @default.
- W2756993541 creator A5017742394 @default.
- W2756993541 creator A5017871993 @default.
- W2756993541 creator A5020744387 @default.
- W2756993541 creator A5021020646 @default.
- W2756993541 creator A5022142463 @default.
- W2756993541 creator A5026307267 @default.
- W2756993541 creator A5026377752 @default.
- W2756993541 creator A5027993808 @default.
- W2756993541 creator A5029886595 @default.
- W2756993541 creator A5030244193 @default.
- W2756993541 creator A5030907652 @default.
- W2756993541 creator A5032018810 @default.
- W2756993541 creator A5034364156 @default.
- W2756993541 creator A5035034281 @default.
- W2756993541 creator A5035180962 @default.
- W2756993541 creator A5038251079 @default.
- W2756993541 creator A5041528285 @default.
- W2756993541 creator A5043192106 @default.
- W2756993541 creator A5047979020 @default.
- W2756993541 creator A5048797041 @default.
- W2756993541 creator A5049613521 @default.
- W2756993541 creator A5054596261 @default.
- W2756993541 creator A5055404517 @default.
- W2756993541 creator A5055675303 @default.
- W2756993541 creator A5055891096 @default.
- W2756993541 creator A5057548978 @default.
- W2756993541 creator A5058426906 @default.
- W2756993541 creator A5058437583 @default.
- W2756993541 creator A5058612214 @default.
- W2756993541 creator A5064084880 @default.
- W2756993541 creator A5064146791 @default.
- W2756993541 creator A5065281895 @default.
- W2756993541 creator A5066306728 @default.
- W2756993541 creator A5066589273 @default.
- W2756993541 creator A5069189129 @default.
- W2756993541 creator A5069757827 @default.
- W2756993541 creator A5070488224 @default.
- W2756993541 creator A5076448184 @default.
- W2756993541 creator A5081795373 @default.
- W2756993541 creator A5083135141 @default.
- W2756993541 creator A5084839712 @default.
- W2756993541 creator A5086064578 @default.
- W2756993541 date "2017-10-30" @default.
- W2756993541 modified "2023-10-15" @default.
- W2756993541 title "EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis" @default.
- W2756993541 cites W1132113666 @default.
- W2756993541 cites W1500543702 @default.
- W2756993541 cites W1540467169 @default.
- W2756993541 cites W1548476693 @default.
- W2756993541 cites W1567449627 @default.
- W2756993541 cites W161846266 @default.
- W2756993541 cites W1877156325 @default.
- W2756993541 cites W1939509546 @default.
- W2756993541 cites W1963619764 @default.
- W2756993541 cites W1964354442 @default.
- W2756993541 cites W1965725761 @default.
- W2756993541 cites W1966217315 @default.
- W2756993541 cites W1966794651 @default.
- W2756993541 cites W1970337654 @default.
- W2756993541 cites W1974435993 @default.
- W2756993541 cites W1974753751 @default.
- W2756993541 cites W1975077467 @default.
- W2756993541 cites W1975797517 @default.
- W2756993541 cites W1979611188 @default.
- W2756993541 cites W1979871405 @default.
- W2756993541 cites W1980806499 @default.
- W2756993541 cites W1981066263 @default.
- W2756993541 cites W1982085915 @default.
- W2756993541 cites W1984360617 @default.
- W2756993541 cites W1984780114 @default.
- W2756993541 cites W1984872163 @default.
- W2756993541 cites W1984973837 @default.
- W2756993541 cites W1985192614 @default.
- W2756993541 cites W1986404685 @default.
- W2756993541 cites W1986517239 @default.
- W2756993541 cites W1988632600 @default.
- W2756993541 cites W1990128650 @default.
- W2756993541 cites W1990684266 @default.
- W2756993541 cites W1990953521 @default.
- W2756993541 cites W1990995622 @default.
- W2756993541 cites W1993555827 @default.
- W2756993541 cites W1995626552 @default.
- W2756993541 cites W1996748765 @default.
- W2756993541 cites W1997120806 @default.
- W2756993541 cites W1997289406 @default.
- W2756993541 cites W1998207718 @default.
- W2756993541 cites W2005083342 @default.
- W2756993541 cites W2007741297 @default.
- W2756993541 cites W2009189426 @default.
- W2756993541 cites W2009267110 @default.
- W2756993541 cites W2010998136 @default.
- W2756993541 cites W2011847100 @default.
- W2756993541 cites W2013292266 @default.